Collagen stimulation
PDLLA microparticles support fibroblast activity and promote gradual formation of new collagen, helping improve firmness, elasticity and structural support.
SCULPTIVA COLLAGEN BIOSTIMULATOR
An advanced hybrid collagen biostimulator combining Poly-D,L-Lactic Acid (PDLLA) with Hyaluronic Acid (HA). Designed to support gradual collagen regeneration while providing immediate hydration for smooth, progressive and natural-looking results.
A hybrid formulation that combines immediate hydration with progressive collagen regeneration and gradual volume restoration.
PDLLA microparticles support fibroblast activity and promote gradual formation of new collagen, helping improve firmness, elasticity and structural support.
Hyaluronic Acid provides immediate hydration while complementing the longer-term collagen-stimulating action of PDLLA.
As new collagen develops, skin quality and volume improve progressively for balanced and natural-looking results.
Two complementary components working together in one formulation.
Sculptiva contains spherical PDLLA microparticles designed to interact with surrounding tissue and support the body's natural collagen-production process.
Over time, newly formed collagen contributes to improved skin density, structural support and gradual restoration of volume.
Stimulate → Regenerate Restore
Sculptiva PDLLA + HA is designed for professional treatment of selected facial and body areas where improvement in skin quality, structural support or volume is desired.
| Product | Sculptiva PDLLA + Hyaluronic Acid |
|---|---|
| Composition | 170 mg Poly-D,L-Lactic Acid (PDLLA); 30 mg Hyaluronic Acid (HA) |
| Total content | 200 mg |
| Package | 1 vial × 200 mg |
| Particle size | 30–60 μm |
| Recommended injection depth | Subcutaneous tissue / Deep dermis |
| Expected duration | Up to 18–24 months* |
| Reconstitution | 3 mL sterile water for injection or normal saline |
| Recommended cannula | 25G, 4050 mm |
Suggested professional treatment parameters based on individual clinical assessment.
Recommended per treatment session.
Suggested between sessions when additional treatment is required.
Follow-up treatment may be considered after approximately 12 months based on individual clinical evaluation.
Contact KCON Co., Ltd. for product, wholesale and distribution information.